Richiedi una copia del documento: Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations on the KCNJ11 (KIR6.2)gene.

Captcha code
Annulla